Blattner, C., Fleming, V., Bitsch, R., Himmelhan, B., Altevogt, P., Gebhardt, C., . . . Umansky, V. (2018). CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions. Cancer research, 78(1), . https://doi.org/10.1158/0008-5472.CAN-17-0348
Chicago Style (17th ed.) CitationBlattner, Carolin, Viktor Fleming, Rebekka Bitsch, Bianca Himmelhan, Peter Altevogt, Christoffer Gebhardt, Torsten Schulze, Jochen Utikal, and Viktor Umansky. "CCR5+ Myeloid-derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions." Cancer Research 78, no. 1 (2018). https://doi.org/10.1158/0008-5472.CAN-17-0348.
MLA (9th ed.) CitationBlattner, Carolin, et al. "CCR5+ Myeloid-derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions." Cancer Research, vol. 78, no. 1, 2018, https://doi.org/10.1158/0008-5472.CAN-17-0348.